Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis
This study has been completed.
Sponsor:
Bayhill Therapeutics
Information provided by:
Bayhill Therapeutics
ClinicalTrials.gov Identifier:
NCT00103974
First received: February 17, 2005
Last updated: April 4, 2008
Last verified: February 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | March 2007 |
| Estimated Primary Completion Date: | No date given |
No publications provided by Bayhill Therapeutics
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):